139 related articles for article (PubMed ID: 38296711)
21. Malignant transformation of oral proliferative verrucous leukoplakia: a series of 48 patients with suggestions for management.
Favia G; Capodiferro S; Limongelli L; Tempesta A; Maiorano E
Int J Oral Maxillofac Surg; 2021 Jan; 50(1):14-20. PubMed ID: 32586723
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
[TBL] [Abstract][Full Text] [Related]
23. The stromal immunoexpression of CLIC4 may be related to the difference in the biological behavior between oral squamous cell carcinoma and oral verrucous carcinoma.
Xerez MC; Barros CC; Queiroz SI; Silveira ÉJ; Costa AD
Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e418-e424. PubMed ID: 37026609
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of verrucous hyperplasia, verrucous carcinoma and squamous cell carcinoma as part of the clinicopathologic spectrum of oral proliferative verrucous leukoplakia: A literature review and analysis.
Akrish S; Eskander-Hashoul L; Rachmiel A; Ben-Izhak O
Pathol Res Pract; 2019 Dec; 215(12):152670. PubMed ID: 31630872
[TBL] [Abstract][Full Text] [Related]
25. Proliferative verrucous leukoplakia: a clinicopathological comparative study.
Alkan U; Bachar G; Nachalon Y; Zlotogorsky A; Levin EG; Kaplan I
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):1027-1033. PubMed ID: 35065850
[TBL] [Abstract][Full Text] [Related]
26. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
Bagan JV; Jimenez Y; Sanchis JM; Poveda R; Milian MA; Murillo J; Scully C
J Oral Pathol Med; 2003 Aug; 32(7):379-82. PubMed ID: 12846783
[TBL] [Abstract][Full Text] [Related]
27. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
28. Proliferative verrucous leukoplakia: report of two cases and a discussion of clinicopathology.
Greer RO; McDowell JD; Hoernig G
J Calif Dent Assoc; 1999 Apr; 27(4):300-5, 308-9. PubMed ID: 10528563
[TBL] [Abstract][Full Text] [Related]
29. Aggressive, multifocal oral verrucous leukoplakia: proliferative verrucous leukoplakia or not?
Ghazali N; Bakri MM; Zain RB
J Oral Pathol Med; 2003 Aug; 32(7):383-92. PubMed ID: 12846784
[TBL] [Abstract][Full Text] [Related]
30. Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG; Suarez P; el-Naggar AK
Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
[TBL] [Abstract][Full Text] [Related]
31. Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma.
Deng Z; Wang Y; Fang X; Yan F; Pan H; Gu L; Xie C; Li Y; Hu Y; Cao Y; Tang Z
Cancer Gene Ther; 2017 Jul; 24(7):282-288. PubMed ID: 28621315
[TBL] [Abstract][Full Text] [Related]
32. On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment.
Herreros-Pomares A; Hervás D; Bagan-Debón L; Jantus-Lewintre E; Gimeno-Cardona C; Bagan J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834903
[TBL] [Abstract][Full Text] [Related]
33. Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia.
Sihavong P; Kitkumthorn N; Srimaneekarn N; Bumalee D; Lapthanasupkul P
Head Neck Pathol; 2021 Jun; 15(2):408-415. PubMed ID: 32720035
[TBL] [Abstract][Full Text] [Related]
34. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
35. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
36. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
Gandolfo S; Castellani R; Pentenero M
J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
[TBL] [Abstract][Full Text] [Related]
37. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
Rintala M; Vahlberg T; Salo T; Rautava J
Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
[TBL] [Abstract][Full Text] [Related]
38. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
39. Inter-observer Variability in the Diagnosis of Proliferative Verrucous Leukoplakia: Clinical Implications for Oral and Maxillofacial Surgeon Understanding: A Collaborative Pilot Study.
Upadhyaya JD; Fitzpatrick SG; Cohen DM; Bilodeau EA; Bhattacharyya I; Lewis JS; Lai J; Wright JM; Bishop JA; Leon ME; Islam MN; Seethala R; Padilla RJ; Carlos R; Müller S; Thompson LDR
Head Neck Pathol; 2020 Mar; 14(1):156-165. PubMed ID: 30972634
[TBL] [Abstract][Full Text] [Related]
40. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA
Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
